Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel acetyl-CoA carboxylase inhibitors developed in India

July 31, 2012

Cadila Healthcare divulges novel LDL receptor ligands

July 31, 2012

Takeda resubmits alogliptin product NDAs

July 30, 2012

Arena Pharmaceuticals transfers NDA rights to Eisai

July 30, 2012

Chinese researchers discover novel DPP IV inhibitors

July 30, 2012

FDA approves Vascepa to reduce triglyceride levels in adults with severe hypertriglyceridemia

July 27, 2012

U.S. researchers report novel glucagon receptor agonists

July 27, 2012

Biodel awarded NIH grant to develop concentrated ultrarapid-acting insulin

July 27, 2012

New protein kinase inhibitors synthesized at Sanofi

July 26, 2012

European Commission approves combination tablet for type 2 diabetes

July 25, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...